" ... a platform technology, a tried and proven patent portfolio, and new market opportunities knocking on its door."

Key attributes of pulse oximetry firm Masimo, cited by BMO analyst Joanne Wuensch as reasons for creating the company's highly desirable position in the med-tech universe. "BMO: Masimo's big opportunities launched by 'better mousetrap,'" pp. 1, 5.